Nightingale Health Oyj Future Growth
Future criteria checks 2/6
Nightingale Health Oyj is forecast to grow earnings and revenue by 23.7% and 52.4% per annum respectively while EPS is expected to grow by 23.9% per annum.
Key information
23.7%
Earnings growth rate
23.9%
EPS growth rate
Healthcare earnings growth | 19.9% |
Revenue growth rate | 52.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 13 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 25 | -6 | -7 | -1 | 1 |
6/30/2026 | 15 | -12 | -13 | -9 | 1 |
6/30/2025 | 9 | -17 | -15 | -11 | 1 |
6/30/2024 | 5 | -16 | -14 | -10 | 1 |
12/31/2023 | 4 | -18 | -11 | -8 | N/A |
9/30/2023 | 4 | -18 | -12 | -7 | N/A |
6/30/2023 | 4 | -18 | -12 | -7 | N/A |
3/31/2023 | 4 | -18 | -14 | -8 | N/A |
12/31/2022 | 3 | -19 | -16 | -9 | N/A |
9/30/2022 | 3 | -17 | -15 | -8 | N/A |
6/30/2022 | 2 | -16 | -15 | -7 | N/A |
3/31/2022 | 2 | -14 | -12 | -5 | N/A |
12/31/2021 | 3 | -12 | -9 | -3 | N/A |
9/30/2021 | 2 | -11 | -7 | -3 | N/A |
6/30/2021 | 2 | -10 | -5 | -2 | N/A |
3/31/2021 | 2 | -8 | -7 | -3 | N/A |
12/31/2020 | 2 | -5 | -9 | -3 | N/A |
9/30/2020 | 2 | -4 | -10 | -3 | N/A |
6/30/2020 | 2 | -4 | -11 | -3 | N/A |
6/30/2019 | 2 | -4 | -7 | -4 | N/A |
6/30/2018 | 2 | -3 | N/A | N/A | N/A |
6/30/2017 | 2 | -1 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NGHL.F is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NGHL.F is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NGHL.F is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NGHL.F's revenue (52.4% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: NGHL.F's revenue (52.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NGHL.F's Return on Equity is forecast to be high in 3 years time